Did I get your attention? I hope so…because there is no uncle Harry and there is no Acorn Diet.
Uncle Harry cited above in the title is anecdotal evidence. Someone’s story is supposed to prove validity. I don’t mean to be rude here, but maybe it took Uncle Harry six months to lose 37 pounds, not two weeks. Maybe Uncle Harry’s picture of ‘before and after’ isn’t actually what it appears to be. Maybe uncle Harry was doing something along with the Acorn Diet that they are not telling us about. Get the picture? These ‘Uncle Harry’ stories abound in articles and advertisements that are trying to get you to buy. They work.
They are generally void of any way for you to determine their validity.
People buy anyway.
On the net (and in print), anecdotal (Uncle Harry) evidence will always confront us. It’s best not to base your decisions on this type of hearsay information. The reality is that even some recognized experts, who wield powerful influence, can lead us astray.
Credentials Are Nice, But Don’t Guarantee Validity
A number of years ago, one of the most prominent scientists in the world (Nobel Prize in chemistry, among numerous other awards), Dr. Linus Pauling, made a strong and compelling case for mega dosing vitamin C. Credentials and accomplishments don’t get any better than his. Vitamin C, based on his research, was a powerful anti-cancer substance when taken in large doses. At that time, that was all I needed to know– Linus Pauling? ….vitamin C? ….no brainer! I jumped on this. I was downing C tablets the size of horse pills.
After years of clinical tests and trials, I am not aware of any conclusive clinical evidence that has proven mega doses of vitamin C to be effective as a cure for cancer.
What’s the consumer of health and fitness information to do?
For this, I will suggest the admonition spoken in the boxing ring before the bout begins, “Protect yourself at all times!”
Keeping It Real,
Steven
The Senior Health and Fitness Blog by Steven Siemons is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.